
Genomic Differences Impact Real World Use of Elacestrant in Breast Cancer
Seth Wander, MD, PhD, a medical oncologist at the Massachusetts General Hospital and instructor in medicine at Harvard Medical School, discusses genomic variations effect on elacestrant (Orserdu) in ESR1-mutated breast cancer from findings in real-world …